Introduction
Deep brain stimulation (DBS) has been used with an increasing frequency to treat patients with refractory epilepsy who were not good candidates for conventional resective surgery. Two large randomised clinical trials showed that DBS was safe and effective in the treatment of refractory epilepsy. Fisher et al. 1 reported the effectiveness of intermittent anterior thalamic stimulation, while Morrell et al. 2 studied the outcome after responsive DBS, in a study that included a significant number of patients with temporal lobe epilepsy.
Hippocampal DBS (Hip-DBS) has been rarely reported in the literature. The rationale for Hip-DBS was based on the relevant role played by the hippocampus in both seizure generation and spread, as frequently seen during invasive neurophysiologic monitoring and surgery. Presently, all series included a relatively small number of patients, used different stimulation paradigms and recruited heterogeneous patient populations. [3] [4] [5] [6] [7] [8] We present the results obtained from a series of patients with refractory temporal lobe epilepsy who underwent Hip-DBS.
Methods
Nine consecutive adult patients (seven men) with TLE who were surgically treated between 2009 and 2011 at the Hospital Brigadeiro Epilepsy Surgery Program were studied. The preoperative work-up consisted of clinical history, neurological examination, interictal and ictal EEG, and MRI.
Preoperative patient characteristics such as sex, age at seizure onset, age at presentation, seizure type and frequency, and antiepileptic drug (AED) regimen were recorded.
The clinical diagnosis was based on the International Classification of Seizures (1981) and Epileptic Syndromes (1989). The following clinical characteristics were considered diagnostic for TLE: simple partial seizures (SPS) of the de´jà vu or jamais vu type, or SPS including epigastric or psychic manifestations (i.e., fear) Purpose: In this study, we present the results obtained from a series of patients with refractory temporal lobe epilepsy (r-TLE) who underwent hippocampal deep brain stimulation (Hip-DBS). Methods: Nine consecutive adult patients were studied. Low-frequency and high-frequency stimulation was carried out immediately after the insertion of each electrode. Chronic continuous high-frequency stimulation was used during treatment. The mean follow-up time was 30.1 months. The mean age of the patients was 37.2 years. The MRI scan was normal in three patients; four patients had bilateral mesial temporal sclerosis (MTS), and two had unilateral MTS. Results: The patients with unilateral MTS received unilateral implantation and experienced a 76% and an 80% reduction in seizure frequency after Hip-DBS. All patients with normal MRI scans were implanted bilaterally. Two of these patients received unilateral activation of the electrodes and experienced a 97% and an 80% reduction in seizure frequency; the third patient had bilateral activation of the device and was a non-responder. All patients with bilateral MTS were implanted bilaterally. Three of these patients received unilateral activation of the device and experienced a 66%, a 66% and a 100% reduction in seizure frequency after Hip-DBS; one patient had bilateral electrode activation, and was a non-responder. Whenever present, generalised tonic-clonic seizures disappeared completely after Hip-DBS. Conclusions: Although performed on a relatively small number of patients, Hip-DBS was safe and effective in our patients with r-TLE. Seven of the nine patients were considered responders. Hip-DBS might represent a useful therapeutic option in patients with refractory temporal lobe epilepsy who were not candidates for resective surgery or have had previous failed procedures.
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followed by complex partial seizures (CPS) characterised by staring and masticatory automatisms, which may be accompanied by superior limb automatisms or contralateral superior limb dystonia. All patients had 32-channel interictal and ictal EEG recordings (10-20 system; at least three seizures recorded) including zygomatic electrodes. The presence of temporal lobe interictal spiking and the absence of extra-temporal discharges were considered findings related to TLE.
All patients had MRI examinations including sequences that allowed the adequate study of the hippocampal formation: 1 mm thick (0.3 mm interval) FLAIR, T2 and IR coronal slices perpendicular to the hippocampal axis; 3 mm thick T1, T2, gradient echo, FLAIR and IR axial slices and T1 sagittal slices. Images were visually reviewed by two members of the epilepsy team independently.
Patients underwent Hip-DBS under general anaesthesia and intra-operative scalp EEG monitoring. Electrodes (Kinetra system, 3387 Electrodes, Medtronic Inc., Minneapolis) were inserted with the patient in a prone position, through occipital burr holes. Planning was based on stereotactic CT/MRI fusion; the distal contact of the electrode was aimed at the anterior hippocampal head and inserted through the occipital burr hole along the axis of the hippocampus proper, as determined by the fused CT/MRI datasets. Intra-operative neuronavigation was used during electrode insertion. Intra-operative low frequency (6 Hz; 4 V; 300 ms) and high frequency (130 Hz; 4 V; 300 ms) stimulation was carried out immediately after the insertion of each electrode. The generator was turned off after this intra-operative neurophysiological study and programmed on an out-patient basis after the skin stitches were removed. A post-operative volumetric CT scan documented the exact position of the electrode.
Chronic continuous high frequency stimulation was used during treatment (1-3.5 V; 130 Hz; 300 ms). Bipolar continuous stimulation between the contacts of the more distal and the more proximal electrodes was carried out, aiming to stimulate the entire implanted area. The voltage was increased in 0.2 V increments in 2-week intervals, to a maximum of 3.5 V, or until the patient was rendered seizure-free or adverse effects appeared. The reduction in seizure frequency was studied in each patient after Hip-DBS. Follow-up time ranged from 15 to 50 months (mean = 30.1 months). Medications were kept stable during the study. Patients with at least a 50% reduction in seizure frequency were considered responders.
In this sample, age ranged from 23 to 53 years (mean = 37.2). Age of seizure onset ranged from 0.5 to 22 years (mean = 11.7 years).
Interictal EEG showed bilateral temporal lobe spiking in seven patients (Patients I, II, III, VI, VII, and VIII), and unilateral temporal lobe spiking in the other two (Patients IV and V). Ictal recordings showed seizures arising mainly from the left temporal lobe in five patients (Patients I, II, III, V and VI) and from the right temporal lobe in four patients (Patients IV, VII, VIII, and IX).
The MRI was normal in three patients (Patients III, VI, and VIII). Four patients had bilateral mesial temporal sclerosis (Patients II, V, VII, and IX) and two had unilateral mesial temporal sclerosis (Patients I and IV; one left, and one right). (Table 1) Patients were included if they were not good candidates for resection (i.e., presence of bilateral MTS, left temporal lobe epilepsy with normal MRI) or declined to undergo resective surgery (i.e., unilateral MTS).
The Student's t-test was used for statistical analyses (p < 0.05 was considered significant).
Results
In six patients (Patients I, II, III, V, VIII, and IX), an increase in temporal lobe spiking was observed unilaterally at the time of electrode insertion, as noted in a previous study 13 ; in two patients (Patients IV and VIII), a bilateral spiking increase was noted. In all patients, an ipsilateral temporal lobe recruiting response (timelocked spike-like activity) was noted during low frequency acute stimulation. In six patients (Patients I, II, III, VI, VII, and VIII), high frequency intra-operative hippocampal stimulation reduced or abolished interictal spiking. We did not observe any increase in spike frequency after high-frequency intra-operative Hip-DBS or any after-discharges after low-frequency intra-operative stimulation.
Hip-DBS was able to reduce seizure frequency in this series (p < 0.05). Six patients were implanted bilaterally (Patients II, III, V, VI, VII, VIII and IX) and two unilaterally (Patients I and IV). The side defined by the surface ictal recordings was initially activated in those patients who received bilateral implantation; the second side was activated only after stimulation of the first side failed to provide seizure frequency reduction or disappearance. The two patients with unilateral mesial temporal sclerosis, Patients I and IV, received unilateral implantation and experienced a 76% and an 80% reduction in seizure frequency after Hip-DBS, respectively. In one of these patients (Patient I), generalised tonic-clonic seizures disappeared completely. All three patients with a normal MRI (Patients III, VI, and VIII) were implanted bilaterally. Two of these patients, Patients III and VIII, had unilateral activation of the electrodes and experienced a 97% and an 80% reduction in seizure frequency, respectively; the third patient (Patient VI) had bilateral activation of the device and was a non-responder (12% reduction in seizure frequency). All four patients with bilateral mesial temporal sclerosis (Patients II, V, VII, and IX) were implanted bilaterally. Three of these patients, Patients II, VII and IX, had unilateral activation of the device and experienced a 66%, a 66% and a 100% reduction in seizure frequency after Hip-DBS, respectively; one In four patients (Patients I, II, VII and IX), a seizure frequency decrease greater than 50% was initially noted (honeymoon effect), and attributed to a microlesional effect (mean duration = 4.5 weeks). These patients waited for their seizure frequency to return to baseline before having their generators activated.
Duration and frequency of the stimuli were kept the same during the study (300 ms; 130 Hz). Voltage ranged from 1-3.5 V (mean = 2.2 V). Three patients (Patients I, II and V) had increased seizure frequency while trying to increase voltage faster than usual (at 0.5 V); an adequate titration using 0.2 V increments made it possible to increase voltage in these patients without any adverse events. One patient needed explantation of the device 2 years after surgery due to infection related to trauma with direct impact to the generator (Patient IX). There was no other morbidity or mortality.
Post-operative CT scans demonstrated an adequate positioning of the electrodes in all patients.
Discussion
Although it included a relatively small number of patients, this prospective cohort showed that Hip-DBS was safe and effective in our patients with refractory temporal lobe epilepsy. Seven of the nine patients were considered responders, and seizure frequency reduction and seizure freedom rates were higher than those reported after thalamic stimulation and previous Hip-DBS series, 9-11 although we are likely comparing different patient populations. There was no difference regarding seizure outcome after Hip-DBS among the different aetiologies as defined by MRI. Velasco et al. 12 suggested that patients with a normal MRI would respond better to Hip-DBS, but this was not noted in this series. Hip-DBS was extremely effective in the control of generalised tonic-clonic seizures in this patient population. We used electrodes developed for the treatment of Parkinson's disease in this series. These quadripolar electrodes span a length of 1.15 cm, meaning that we were actually stimulating the head and anterior portions of the body of the hippocampus, and not the whole hippocampus. A more adequate electrode would need to be 3.5 cm in length, and include more contacts (possibly 8), to be able to more adequately cover the hippocampal formation. Additionally, it is likely that some of the contacts were located within the parahippocampus itself; this might have occurred because the hippocampus is a slightly arched structure. In patients with severe mesial temporal sclerosis, the hippocampus is very small and hard, and might cause deviation of the electrode into the parahippocampus or the lateral ventricle. We believe that improvement in hardware configuration might lead to results even better than those reported here.
Contrary to thalamic stimulation, where seizure frequency increase is rarely seen after a voltage increase of 0.5 V, such increases in voltage might lead to seizure frequency worsening during Hip-DBS. Voltage increments during Hip-DBS should not exceed 0.2 V. Even those patients who showed seizure frequency worsening after a 0.5 V increase were able to tolerate much higher voltages when 0.2 V increments were used. The mean final voltage in the present series was lower than that in patients who underwent thalamic stimulation.
Intra-operative low-frequency stimulation generated a recruiting rhythm restricted to the stimulated temporal lobe, as we noted in a previous study. 13 This was in sharp contrast to the intraoperative findings after thalamic stimulation, during which widespread, bilateral recruiting rhythms were noted after unilateral stimulation. We considered the recording of such localised recruiting rhythms as a good indicator of adequate electrode placement and hardware functioning. We tested 130 Hz highfrequency stimulation in this series. In a previous study, 12 we
showed that turning the generator off after acute high-frequency intra-operative stimulation that abolished spiking led to the reappearance of spikes, which could be abolished again by restarting the stimulation. This was a reproducible phenomenon, favouring a Hip-BDS effect and not a spontaneous fluctuation of spike frequency. Half of these patients appeared to experience a microlesional effect inducing a seizure frequency decrease immediately after implantation, without generator activation.
14 Although this effect is also present in patients who underwent anterior thalamic stimulation, it appears to be much more frequent in patients receiving Hip-DBS. Patients were unaware of the Hip-DBS. We used the same stimulation paradigm for patients with either a normal MRI or MTS. Although neuropsychological findings were not the aim of this study, we observed no self-reported memory deterioration, even in those patients who received bilateral Hip-DBS. Statistical analysis did not show any differences related to outcome between patients with a normal MRI or MTS, although the number of patients is too small for an adequate analysis.
We did not see improvement in our patients who shifted from unilateral to bilateral Hip-DBS, as was noted by Vonck et al.; the small number of patients worldwide receiving bilateral Hip-DBS precludes any adequate conclusion at this point. We used continuous Hip-DBS in this series; others have used either intermittent or cycled stimulation. Because there are no randomised trials comparing the different stimulation paradigms, the optimal parameters for Hip-DBS remain unknown. Hip-DBS might represent a useful therapeutic option in patients with refractory temporal lobe epilepsy who were not candidates for resective surgery or have had previous failed procedures.
